NanJing Pharmaceutical Company Limited (600713.SS)
CNY 5.2
(-0.38%)
CNY 5.2
(-0.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.9 Billion | -682.31 Million | 695.33 Million | -1.15 Billion | 1 Billion | -366.9 Million |
| Net Income | 577.82 Million | 715.91 Million | 610.55 Million | 470.03 Million | 431.55 Million | 345.83 Million |
| Depreciation & Amortization | 281.73 Million | 260.47 Million | 241.47 Million | 128.6 Million | 124.94 Million | 97.36 Million |
| Deferred income taxes | -7.2 Million | -29.84 Million | -2.94 Million | -7.14 Million | 492.26 Thousand | 5.55 Million |
| Stock-based compensation | 17.59 Million | 16.56 Million | - | - | - | - |
| Change in working capital | 537.81 Million | -2.1 Billion | -502.81 Million | -2.02 Billion | 40.49 Million | -1.13 Billion |
| Other non-cash items | 501.04 Million | 460.1 Million | 346.1 Million | 272.79 Million | 406.97 Million | 323.11 Million |
| Investing Cash Flow | -153.04 Million | -59.26 Million | -224.51 Million | -216 Million | -288.56 Million | -218.45 Million |
| Investments in PPE | -158.21 Million | -155.27 Million | -306.53 Million | -246.97 Million | -300.71 Million | -311.51 Million |
| Acquisitions | 29.12 Million | 122.41 Million | -1.8 Million | -28.55 Million | -69.35 Million | -11.4 Million |
| Investment purchases | -24 Million | -122.41 Million | 0.79 | 285.93 Million | -500 Thousand | -400 Thousand |
| Sales/Maturities of investments | 45.08 Thousand | 2.7 Million | 45.93 Million | 20.55 Million | 2.44 Million | 1.47 Million |
| Other Investing Activities | 1.00 | 93.31 Million | 37.89 Million | -246.97 Million | 79.56 Million | 103.39 Million |
| Financing Cash Flow | -1.17 Billion | 466.62 Million | 30.84 Million | 749.33 Million | -960.76 Million | 1.48 Billion |
| Debt repayment | -461.07 Million | -75.13 Million | -27.95 Billion | -22.51 Billion | -18.39 Billion | -14.37 Billion |
| Dividends payments | -587.94 Million | -157.05 Million | -114.57 Million | -104.16 Million | -104.16 Million | -368.87 Million |
| Common Stock Repurchased | -165.48 Thousand | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -600.6 Million | 874.37 Million | 28.91 Billion | 23.61 Billion | 17.93 Billion | 16.22 Billion |
| Accounts receivables | 3.8 Billion | -4.98 Billion | -1.36 Billion | -1.81 Billion | -857.36 Million | -1.9 Billion |
| Accounts payables | -3.25 Billion | 4.18 Billion | 1.32 Billion | 92.97 Million | 1.56 Billion | 855.47 Million |
| Inventory | -13.44 Million | -1.27 Billion | -460.58 Million | -352.75 Million | -664.43 Million | -91.22 Million |
| Other working capital | -1.00 | -29.84 Million | -2.94 Million | 54.84 Million | 492.26 Thousand | -1.04 Billion |
| Cash at beginning of period | 2.32 Billion | 1.89 Billion | 1.39 Billion | 2.01 Billion | 2.25 Billion | 1.35 Billion |
| Cash at end of period | 2.37 Billion | 1.61 Billion | 1.89 Billion | 1.39 Billion | 2.01 Billion | 2.25 Billion |
| Capital Expenditure | -158.21 Million | -155.27 Million | -306.53 Million | -246.97 Million | -300.71 Million | -311.51 Million |
| Effect of forex changes on cash | -532.07 Million | 0.78 | 0.79 | 0.39 | 0.33 | 0.18 |
| Net cash flow / Change in cash | 44.38 Million | -274.95 Million | 501.66 Million | -619.13 Million | -245.37 Million | 897.76 Million |
| Free Cash Flow | 1.75 Billion | -837.59 Million | 388.79 Million | -1.39 Billion | 703.24 Million | -678.42 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 130.56 Million | 152.23 Million | 159.08 Million | 137.53 Million | 577.82 Million | 131.65 Million |
| Depreciation & Amortization | - | 70.5 Million | 70.5 Million | 70.3 Million | 281.73 Million | -126.41 Million |
| Deferred income taxes | - | - | - | - | -7.2 Million | -1.42 Billion |
| Stock-based compensation | - | 3.58 Million | - | 17.59 Million | 17.59 Million | -8.87 Million |
| Change in working capital | - | -3.15 Billion | - | 3.79 Billion | 537.81 Million | 1.55 Billion |
| Other non-cash items | -669.76 Million | 1.45 Billion | -4.05 Billion | 6.18 Billion | 501.04 Million | -1.89 Billion |
| Investing Cash Flow | -106.62 Million | -25.02 Million | -363.84 Million | -49.67 Million | -153.04 Million | -69.33 Million |
| Investments in PPE | -110.32 Million | -23.11 Million | -345.16 Million | -63.33 Million | -158.21 Million | -47.71 Million |
| Acquisitions | 3.7 Million | -1.02 Million | 2.91 Million | 13.66 Million | 29.12 Million | 47.63 Thousand |
| Investment purchases | - | -3.6 Million | -21.6 Million | - | -24 Million | -24 Million |
| Sales/Maturities of investments | - | 3718.00 | 140 Thousand | 35.5 Thousand | 45.08 Thousand | 2.35 Million |
| Other Investing Activities | - | -1.91 Million | -18.54 Million | -35.5 Thousand | 1.00 | -27.99 Thousand |
| Financing Cash Flow | -597.02 Million | -820.2 Million | 3.41 Billion | -5.14 Billion | -1.17 Billion | 1.04 Billion |
| Debt repayment | -482.1 Million | -423.02 Million | -3.54 Billion | -4.99 Billion | -461.07 Million | -7.39 Billion |
| Dividends payments | - | -209.47 Million | -93.57 Million | -89.29 Million | -587.94 Million | -88.73 Million |
| Common Stock Repurchased | 2.11 Million | -2.11 Million | - | -165.48 Thousand | -165.48 Thousand | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -117.03 Million | -33.23 Million | -133.66 Million | -32.37 Million | -600.6 Million | 8.52 Billion |
| Accounts receivables | - | -3.03 Billion | - | 3.8 Billion | 3.8 Billion | 1.35 Billion |
| Accounts payables | - | - | - | - | -3.25 Billion | - |
| Inventory | - | -118.34 Million | - | -13.44 Million | -13.44 Million | 198.63 Million |
| Other working capital | - | - | - | - | -1.00 | - |
| Cash at beginning of period | 2.46 Billion | 1.35 Billion | 2.37 Billion | 1.18 Billion | 2.32 Billion | 1.77 Billion |
| Cash at end of period | 1.15 Billion | 2.04 Billion | 1.63 Billion | 2.37 Billion | 2.37 Billion | 995.25 Million |
| Capital Expenditure | -110.32 Million | -23.11 Million | -345.16 Million | -63.33 Million | -158.21 Million | -47.71 Million |
| Effect of forex changes on cash | - | - | - | -9.55 Million | -532.07 Million | -2.35 Million |
| Net cash flow / Change in cash | -1.3 Billion | 695.15 Million | -733.55 Million | 1.18 Billion | 44.38 Million | -783.81 Million |
| Free Cash Flow | -649.52 Million | 1.51 Billion | -4.23 Billion | 6.32 Billion | 1.75 Billion | -1.8 Billion |
603138
MFG
MADHAV
HELIO
001313
ANDHRAPET